Your browser doesn't support javascript.
loading
CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma.
Roncador, Giovanna; Puñet-Ortiz, Joan; Maestre, Lorena; Rodríguez-Lobato, Luis Gerardo; Jiménez, Scherezade; Reyes-García, Ana Isabel; García-González, Álvaro; García, Juan F; Piris, Miguel Ángel; Montes-Moreno, Santiago; Rodríguez-Justo, Manuel; Mena, Mari-Pau; Fernández de Larrea, Carlos; Engel, Pablo.
Affiliation
  • Roncador G; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre (CNIO), Centro de Investigación Médica en red Cancer (CIBERONC), 28029 Madrid, Spain.
  • Puñet-Ortiz J; Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Barcelona, Casanova 172, 08036 Barcelona, Spain.
  • Maestre L; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre (CNIO), Centro de Investigación Médica en red Cancer (CIBERONC), 28029 Madrid, Spain.
  • Rodríguez-Lobato LG; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.
  • Jiménez S; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
  • Reyes-García AI; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre (CNIO), Centro de Investigación Médica en red Cancer (CIBERONC), 28029 Madrid, Spain.
  • García-González Á; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre (CNIO), Centro de Investigación Médica en red Cancer (CIBERONC), 28029 Madrid, Spain.
  • García JF; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre (CNIO), Centro de Investigación Médica en red Cancer (CIBERONC), 28029 Madrid, Spain.
  • Piris MÁ; Department of Pathology, MD Anderson Cancer Center Madrid, Centro de Investigación Médica en Red Cancer (CIBERONC), 28040 Madrid, Spain.
  • Montes-Moreno S; Department of Pathology, Fundación Jiménez Díaz, Centro de Investigación Médica en Red Cancer (CIBERONC), 28040 Madrid, Spain.
  • Rodríguez-Justo M; Translational Haematopathology Laboratory, Anatomic Pathology Department, Hospital Universitario Marqués de Valdecilla/IDIVAL, CIBERONC, 39008 Santander, Spain.
  • Mena MP; Department of Research Pathology, Cancer Institute, University Collage London, London WC1E 6DD, UK.
  • Fernández de Larrea C; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.
  • Engel P; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
Cancers (Basel) ; 14(9)2022 Apr 26.
Article in En | MEDLINE | ID: mdl-35565280
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: España